Tempus Wealth Planning’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963K Buy
7,491
+554
+8% +$64.8K 0.19% 131
2026
Q1
$834K Buy
6,937
+64
+0.9% +$7.39K 0.19% 139
2025
Q4
$723K Buy
6,873
+754
+12% +$70.8K 0.17% 143
2025
Q3
$514K Buy
6,119
+519
+9% +$42.7K 0.12% 175
2025
Q2
$443K Sell
5,600
-353
-6% -$28.1K 0.11% 175
2025
Q1
$534K Buy
5,953
+170
+3% +$15.9K 0.16% 144
2024
Q4
$575K Sell
5,783
-642
-10% -$66.2K 0.18% 127
2024
Q3
$730K Buy
6,425
+309
+5% +$36.7K 0.27% 100
2024
Q2
$757K Buy
6,116
+411
+7% +$52.9K 0.32% 88
2024
Q1
$753K Buy
5,705
+307
+6% +$37.8K 0.33% 84
2023
Q4
$588K Sell
5,398
-28
-0.5% -$2.91K 0.26% 92
2023
Q3
$559K Sell
5,426
-3,946
-42% -$425K 0.28% 82
2023
Q2
$1.08M Sell
9,372
-216
-2% -$24.5K 0.49% 61
2023
Q1
$1.02M Sell
9,588
-610
-6% -$65.9K 0.5% 54
2022
Q4
$1.13M Buy
10,198
+159
+2% +$16.3K 0.69% 41
2022
Q3
$865K Buy
10,039
+1,760
+21% +$157K 0.58% 46
2022
Q2
$755K Hold
8,279
0.62% 47
2022
Q1
$679K Sell
8,279
-464
-5% -$36.6K 0.48% 54
2021
Q4
$670K Sell
8,743
-794
-8% -$63.2K 0.36% 77
2021
Q3
$716K Hold
9,537
0.41% 69
2021
Q2
$742K Sell
9,537
-247
-3% -$18.4K 0.49% 62
2021
Q1
$720K Buy
9,784
+1,325
+16% +$97.7K 0.76% 35
2020
Q4
$660K Buy
8,459
+555
+7% +$42.4K 0.85% 24
2020
Q3
$626K Hold
7,904
0.91% 22
2020
Q2
$583K Hold
7,904
0.87% 24
2020
Q1
$580K Hold
7,904
0.95% 21
2019
Q4
$686K Buy
+7,904
New +$649K 0.61% 26

Other funds holding MRK

Tempus Wealth Planning's MRK Position: Q2 2026 in Review

Tempus Wealth Planning increased its Merck (MRK) stake by 8% in Q2 2026, buying an estimated $64.8K and bringing the position to 7,491 shares worth $963K. The position accounts for 0.19% of the portfolio, ranked #131.

Tempus Wealth Planning first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.13M in Q4 2022. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tempus Wealth Planning held 7,491 shares of Merck worth $963K as of Q2 2026.
  • Tempus Wealth Planning bought 554 Merck shares in Q2 2026, an estimated $64.8K.
  • Merck made up 0.19% of Tempus Wealth Planning's portfolio in Q2 2026, its #131 holding.
  • Tempus Wealth Planning first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • Tempus Wealth Planning's Merck position peaked at $1.13M in Q4 2022.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.